A118000 Stock Overview
SMEDI Co., Ltd. distributes pharmaceuticals and medical devices in South Korea.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
SMEDI Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩507.00 |
52 Week High | ₩767.00 |
52 Week Low | ₩370.00 |
Beta | 1.28 |
1 Month Change | -3.24% |
3 Month Change | 25.19% |
1 Year Change | -20.28% |
3 Year Change | -77.62% |
5 Year Change | -81.05% |
Change since IPO | -94.61% |
Recent News & Updates
Recent updates
Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%
Mar 07There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release
Mar 22What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 31Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?
Dec 25Shareholder Returns
A118000 | KR Healthcare | KR Market | |
---|---|---|---|
7D | -2.5% | -0.05% | -2.4% |
1Y | -20.3% | 15.0% | 1.9% |
Return vs Industry: A118000 underperformed the KR Healthcare industry which returned 15% over the past year.
Return vs Market: A118000 underperformed the KR Market which returned 1.9% over the past year.
Price Volatility
A118000 volatility | |
---|---|
A118000 Average Weekly Movement | 5.5% |
Healthcare Industry Average Movement | 5.8% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A118000 has not had significant price volatility in the past 3 months.
Volatility Over Time: A118000's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 22 | Soo-Kyung Kim | www.smedi.net |
SMEDI Co., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory.
SMEDI Co., Ltd. Fundamentals Summary
A118000 fundamental statistics | |
---|---|
Market cap | ₩72.39b |
Earnings (TTM) | -₩14.54b |
Revenue (TTM) | ₩55.75b |
1.3x
P/S Ratio-5.0x
P/E RatioIs A118000 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A118000 income statement (TTM) | |
---|---|
Revenue | ₩55.75b |
Cost of Revenue | ₩48.68b |
Gross Profit | ₩7.07b |
Other Expenses | ₩21.61b |
Earnings | -₩14.54b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -101.84 |
Gross Margin | 12.68% |
Net Profit Margin | -26.08% |
Debt/Equity Ratio | 1.8% |
How did A118000 perform over the long term?
See historical performance and comparison